Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population

International Journal of Immunogenetics

Volumn 38, Issue 3, 2011, Pages 201-208

  Coker, A ^a   Arman, A ^b   Soylu, O ^c   Tezel, T ^c   Yildirim, A ^c  

^a ISTANBUL KULTUR UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TURKEY;

EID: 79956260118     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2010.00988.x     Document Type: Article

References (47)

1. Arman, A., Yi{dotless}lmaz, B., Coker, A., Inanc, N. & Direskeneli, H. (2006) Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, 24, 643.
2. Auron, P.E. (1998) The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine and Growth Factor Reviews, 9, 221.
3. Banerjee, I., Pandey, U., Hasan, O.M., Parihar, R., Tripathi, V. & Ganesh, S. (2009) Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. Journal of Thrombosis and Thrombolysis, 27, 88.
4. Bennermo, M., Held, C., Green, F., Strandberg, L.E., Ericsson, C.G., Hansson, L.O., Watkins, H., Hamsten, A. & Tornvall, P. (2004) Prognostic value of plasma interleukin-6 concentrations and the -174G>C and -572G>C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis, 174, 157.
5. Biswas, P., Delfanti, F., Bernasconi, S., Mengozzi, M., Cota, M., Polentarutti, N., Mantovani, A., Lazzarin, A., Sozzani, S. & Poli, G. (1998) Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood, 91, 258.
6. Braunwald, E. (1997) Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. New England Journal of Medicine, 337, 1360.
7. Castell, J.V., Gómez- Lechón, M.J., David, M., Andus, T., Geiger, T., Trullenque, R., Fabra, R. & Heinrich, P.C. (1989) Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letters, 242, 237.
8. Chiappelli, M., Tampieri, C., Tumini, E., Porcellini, E., Caldarera, C.M., Nanni, S. et al. (2005) Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. International Journal of Immunogenetics, 32, 349.
9. Dalmon, J., Laurent, M. & Courtois, G. (1993) The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Molecular and Cellular Biology, 13, 1183.
10. Ferrari, S.L., Ahn-Luong, L., Garnero, P., Humphries, S.E. & Greenspan, S.L. (2003) Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. The Journal of Clinical Endocrinology and Metabolism, 88, 255.
11. Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S. & Woo, P. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102, 1369.
12. Friedewald, W.T., Levi, R.I. & Fredrickson, D.J. (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clinical Chemistry, 18, 499.
13. Fu, H.X., Zhang, J.Y., Li, G.S., Li, Y., Xu, J.L. & Zhao, Z.N. (2006) Study on linkage between polymorphism of interleukin 6 gene -572C/G and susceptibility to myocardial infarction. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 23, 245.
14. Galis, Z.S., Muszynski, M., Sukhova, G.K., Simon-Morrissey, E., Unemori, E.N., Lark, M.W., Amento, E. & Libby, P. (1994) Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circulation Research, 75, 181.
15. Georges, J.L., Loukaci, V., Poirier, O., Evans, A., Luc, G., Arveiler, D., Ruidavets, J.B., Cambien, F. & Tiret, L. (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. Journal of Molecular Medicine, 79, 300.
16. di{dotless} Gi{dotless}ovi{dotless}ne, F.S., Takhsh, E., Blakemore, A.I. & Duff, G.W. (1992) Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Human Molecular Genetics, 1, 450.
17. Heinrich, P.C., Castell, J.V. & Andus, T. (1990) Interleukin-6 and the acute phase response. Biochemical Journal, 265, 621.
18. Hurme, M. & Santtila, S. (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. European Journal of Immunology, 28, 2598.
19. Iacoviello, L., Di Castelnuovo, A., Gattone, M., Pezzini, A., Assanelli, D., Lorenzet, R. et al. (2005) Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at younger age and the response of mononuclear cells to stimulation in vitro. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 222.
20. Ikeda, U., Ikeda, M., Seino, Y., Takahashi, M., Kasahara, T., Kano, S. & Shimada, K. (1993) Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines. Atherosclerosis, 104, 61.
21. Jenny, N.S., Tracy, R.P., Ogg, M.S., Luong le, A., Kuller, L.H., Arnold, A.M., Sharrett, A.R. & Humphries, S.E. (2002) In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 2066.
22. Jia, X., Tian, Y., Wang, Y., Deng, X., Dong, Z., Scafa, N. & Zhang, X. (2010) Association between the interleukin-6 gene -572G/C and -597G/A polymorphisms and coronary heart disease in the Han Chinese. Medical Science Monitor, 16, 103.
23. Kariz, S., Milutinović, A., Bregar, D., Terzić, I., Terzić, R., Lovrecić, L. et al. (2007) The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes. Collegium Antropologicum, 31, 503.
24. Kelberman, D., Hawe, E., Luong, L.A., Mohamed-Ali, V., Lundman, P., Tornvall, P. et al. (2004) Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thrombosis and Haemostasis, 92, 1122.
25. Levenson, J., Giral, P., Razavian, M., Gariepy, J. & Simon, A. (1995) Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 1263.
26. Licastro, F., Chiappelli, M., Caldarera, C.M., Tampieri, C., Nanni, S., Gallina, M. & Branzi, A. (2004) The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mechanisms of Ageing and Development, 125, 575.
27. Lieb, W., Pavlik, R., Erdmann, J., Mayer, B., Holmer, S.R., Fischer, M. et al. (2004) No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. International Journal of Cardiology, 97, 205.
28. Manginas, A., Tsiavou, A., Chaidaroglou, A., Giamouzis, G., Degiannis, D., Panagiotakos, D. & Cokkinos, D.V. (2008) Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coronary Artery Disease, 19, 575.
29. Manzoli, A., Androtti, F., Varlotta, C., Mollichelli, N., Verde, M. & Van de Greed, W. (1999) Allelic polymorphism of the IL-1Ra gene in patients with acute or stable presentation of ischaemic heart disease. Cardiologia, 44, 825.
30. Martí-Carvajal, A.J., Solà, I., Lathyris, D. & Salanti, G. (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database of Systematic Reviews, 7, CD006612.
31. Miller, S.A., Dykes, D.D. & Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
32. Momiyama, Y., Hirano, R., Taniguchi, H., Nakamura, H. & Ohsuzu, F. (2001) Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. Journal of the American College of Cardiology, 38, 712.
33. Nauck, M., Winkelmann, B.R., Hoffmann, M.M., Böhm, B.O., Wieland, H. & März, W. (2002) The interleukin-6G(-174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. Journal of Molecular Medicine, 80, 507.
34. Olofsson, P.S., Sheikine, Y., Jatta, K., Ghaderi, M., Samnegård, A., Eriksson, P. & Sirsjö, A. (2009) A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis. Circulation Journal, 73, 1531.
35. Papanicolaou, D.A., Wilder, R.L., Manolagas, S.C. & Chrousos, G.P. (1998) The pathophysiologic roles of interleukin-6 in human disease. Annals of Internal Medicine, 128, 127.
36. Poci{dotless}ot, F., Molvi{dotless}g, J., Wogensen, L., Worsaae, H. & Nerup, J. (1992) A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. European Journal of Clinical Investigation, 22, 396.
37. Rifai, N. & Ridker, P.M. (2001) Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clinical Chemistry, 47, 28.
38. Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P. et al. (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity, 6, 315.
39. Ross, R. (1999) Atherosclerosis: an inflammatory disease. New England Journal of Medicine, 320, 115.
40. Schieffer, B., Schieffer, E., Hilfiker-Kleiner, D., Hilfiker, A., Kovanen, P.T., Kaartinen, M., Nussberger, J., Harringer, W. & Drexler, H. (2000) Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation, 101, 1372.
41. Sehgal, P.B., Zilberstein, A., Ruggieri, R.-M., May, L.T., Ferguson-Smith, A., Slate, D.L., Revel, M. & Ruddle, F.H. (1986) Human chromosome 7 carries the beta-2 interferon gene. Proceedings of the National Academy of Sciences, 83, 5219.
42. Sekuri, C., Cam, F.S., Sagcan, A., Ercan, E., Tengiz, I., Alioglu, E. & Berdeli, A. (2007) No association of interleukin-6 gene polymorphism (-174G/C) with premature coronary artery disease in a Turkish cohort. Coronary Artery Disease, 18, 333.
43. Steinkasserer, A., Koelble, K. & Sim, R.B. (1991) Length variation within intron 2 of the human IL-1 receptor antagonist gene (IL-1 RN). Nucleic Acid Research, 19, 5095.
44. Tarlow, K., Blakemore, A.I., Lennard, A., Solari, R., Huges, H.N., Steinkasserer, A. & Duff, G.W. (1993) Polymorphism in human IL-1 receptor antogonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Human Genetics, 91, 403.
45. Vamvakopoulos, J.E., Taylor, C.J., Morris-Stiff, G.J., Green, C. & Metcalfe, S. (2002) The IL-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. European Journal of Immunogenetics, 29, 337.
46. Yamada, Y., Izawa, H., Ichihara, S., Takatsu, F., Ishihara, H., Hirayama, H., Sone, T., Tanaka, M. & Yokota, M. (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. New England Journal of Medicine, 347, 1916.
47. Zee, R.Y., Lunze, K., Lindpaintner, K. & Ridker, P.M. (2001) A prospective evaluation of the interleukin-1 receptor antogonist intron 2 gene polymorphism and the risk of myocardial infarction. Thrombosis and Haemostasis, 86, 1141.